Despite the elongation of the mitochondria in lung cancer and neuroblastoma cells treated with Mdivi-1, our additional study indicates that this quinazolinone derivative does not alter mitochondrial morphology and poorly antagonize recombinant DRP1 GTPase activity (Ki >1.2 mM)75. This evidence concerns the gene DNM1L and lung carcinoma.